A detailed history of Scientech Research LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 50,244 shares of TXG stock, worth $798,377. This represents 0.2% of its overall portfolio holdings.

Number of Shares
50,244
Previous 33,032 52.11%
Holding current value
$798,377
Previous $383 Million 53.55%
% of portfolio
0.2%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$11.34 - $14.64 $195,184 - $251,983
17,212 Added 52.11%
50,244 $587 Million
Q2 2025

Aug 14, 2025

BUY
$7.14 - $11.73 $235,848 - $387,465
33,032 New
33,032 $383 Million
Q4 2024

Feb 14, 2025

SELL
$13.18 - $21.31 $234,907 - $379,808
-17,823 Reduced 61.55%
11,136 $160 Million
Q3 2024

Nov 14, 2024

BUY
$15.71 - $23.49 $454,945 - $680,246
28,959 New
28,959 $654 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.